Urokinase-Type Plasminogen Activator and Arthritis Progression: Contrasting Roles in Systemic and Monoarticular Arthritis Models

Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar3171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

THU0694 Effects of ANTI-TNF Therapy on Solubile Urokinase Plasminogen Activator Receptor (SUPAR) Levels in Arthritis

2017English

Urokinase-Type Plasminogen Activator (PLAU; uPA); Thrombin (F2)

Science-Business eXchange
2010English

Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms

Gut
Gastroenterology
1998English

Interaction of Single-Chain Urokinase and Plasminogen Activator Inhibitor Type 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

The Roles of Urokinase-Type Plasminogen Activator in Leukocyte Infiltration and Inflammatory Responses in Mice Corneas Treated With Lipopolysaccharide

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2014English

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea

Medicina
Medicine
2020English

Ligand Binding Regions in the Receptor for Urokinase-Type Plasminogen Activator

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Maspin Binds to Urokinase-Type and Tissue-Type Plasminogen Activator Through Exosite-Exosite Interactions

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans With CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy